Light-activated cornea cell graft to help grafts join your cornea
Bioengineered corneal endothelial graft using photodegradable device to induce graft-host integration
The team is using a light-breakdown gel to help a lab-grown layer of cornea cells attach to damaged corneas and improve vision for people with failing corneal endothelium.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ut Southwestern Medical Center NIH-funded |
| Lab location | 1 site (Dallas, United States) |
| Project ID | NIH-11386989 on NIH RePORTER |
What this research studies
Researchers grow a thin, functional layer of human corneal endothelial cells on a special light-sensitive hydrogel that supports the cells during surgery. After placing the graft in the eye, they use tissue-penetrating light to break down the gel at a controlled pace so the cell layer can settle and join the patient's own cornea. The graft surface is nano-patterned to encourage the cells to behave like normal cornea lining. The group will test how well the cell layer integrates and restores corneal function in animal models before any human testing.
Who could benefit from this research
Good fit: Ideal candidates would be people with corneal endothelial failure (for example Fuchs endothelial dystrophy or bullous keratopathy) who need endothelial replacement but lack or want alternatives to traditional donor tissue.
Not a fit: People with full-thickness corneal scarring, active eye infection, severe ocular surface disease, or other conditions that prevent a healthy host cornea from supporting an endothelial graft are unlikely to benefit from this approach.
Why it matters
Potential benefit: If successful, this approach could give people with endothelial failure a donor-free graft option that integrates better and restores vision without long-term carrier material left in the eye.
How similar studies have performed: Lab-grown corneal endothelial cell sheets have restored vision in animal models, but using a light-degradable, nano-patterned carrier to promote lasting integration is a newer, largely preclinical strategy.
Where this research is happening
Dallas, United States
- Ut Southwestern Medical Center — Dallas, United States (Active)
Researchers
- Principal investigator: Rizwan, Muhammad — Ut Southwestern Medical Center
- Study coordinator: Rizwan, Muhammad
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.